Target intelligence / Profile preview

Immunoglobulin heavy variable 5-78 pseudogene (IGHV5-78)

Target
IGHV5-78
Molecular classification
Other (immunoglobulin variable gene segment, pseudogene)
01

Overview

IGHV5-78 (immunoglobulin heavy variable 5-78) is classified as a pseudogene that belongs to the immunoglobulin heavy chain variable (IGHV) gene family. These gene segments encode the variable domains of immunoglobulin heavy chains, which are critical for antigen binding and immune system diversity. However, as a pseudogene, IGHV5-78 does not produce a functional immunoglobulin protein[1]. While functional IGHV segments are necessary for the generation of antibody repertoires, pseudogenes like IGHV5-78 are generally not transcribed or translated into functional products and are not direct therapeutic targets. There are no known drugs or clinical biomarkers associated with IGHV5-78, and it does not play a defined role in human disease or therapy. Key clarification: While immunoglobulin gene segments as a group are central in B cell immunity and antibody generation, IGHV5-78 itself is notably distinguished as a pseudogene and therefore not a classical drug target or receptor[1]. If a functional IGHV gene is of interest (rather than this pseudogene), a different gene segment should be selected.

Other names
5-78PIGHV578VH5IGHV5-78
02

Biological functions

Antibody gene segment (potentially involved in antibody diversity at the DNA level, but likely non-functional as a protein due to pseudogene status[1])
03

Disease associations

Other (no established direct role in human disease)

Beyond the preview

Go deeper on Immunoglobulin heavy variable 5-78 pseudogene (IGHV5-78).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 5-78 pseudogene (IGHV5-78).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call